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Abstract
Background: Hyperplastic polyps are the most common polypoid lesions of the stomach. Rarely,
they cause gastric outlet obstruction by prolapsing through the pyloric channel, when they arise in
the prepyloric antrum.
Case presentation: A 62-year-old woman presented with intermittent nausea and vomiting of 4
months duration. Upper gastrointestinal endoscopy revealed a 30 mm prepyloric sessile polyp
causing intermittent gastric outlet obstruction. Following submucosal injection of diluted adrenaline
solution, the polyp was removed with a snare. Multiple biopsies were taken from the greater
curvature of the antrum and the corpus. Rapid urease test for Helicobacter pylori yielded a negative
result. Histopathologic examination showed a hyperplastic polyp without any evidence of
malignancy. Biopsies of the antrum and the corpus revealed gastritis with neither atrophic changes
nor Helicobacter pylori infection. Follow-up endoscopy after a 12-week course of proton pomp
inhibitor therapy showed a complete healing without any remnant tissue at the polypectomy site.
The patient has been symptom-free during 8 months of follow-up.
Conclusions: Symptomatic gastric polyps should be removed preferentially when they are
detected at the initial diagnostic endoscopy. Polypectomy not only provides tissue to determine
the exact histopathologic type of the polyp, but also achieves radical treatment.
Background
Gastric outlet obstruction (GOO) presents with nausea
and vomiting and usually develops over weeks to months
[1]. It may be complete or incomplete with intermittent
symptoms. In the past, peptic ulcer disease was consid-
ered as the most common cause of GOO; more recently,
gastric malignancy has become a more frequent entity [2].
The rare causes are bezoars, foreign bodies, Bouveret's
syndrome, hypertrophic pyloric stenosis, and large polyps
of the antrum or pyloric channel [3–6].
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gastrointestinal endoscopic examinations [7]. The most
common type of gastric polyps is hyperplastic polyps,
which account for nearly 85–90% of cases [7,8]. They are
usually seen in adults, over 60 years of age [8]. These pol-
yps are often pinkish, round-shaped, solitary, and small
(<2 cm) and classified as either sessile or pedunculated.
While small polyps tend to be sessile, the larger ones may
have a short stalk [8]. Most of them are localized at the
junction of fundic and pyloric mucosa. Multiple hyper-
plastic polyps are found in 20% of the patients [9].
Until recently it was believed that the hyperplastic polyps
do not undergo malignant transformation, but carcino-
mas associated with hyperplastic polyps were reported in
the literature over the past few years [10,11]. Interestingly,
an association between hyperplastic polyps and Helico-
bacter pylori (H. pylori) gastritis has been proposed in some
recent studies [12,13].
In this report, we present a patient who had a gastric
hyperplastic polyp causing GOO and a review of the per-
tinent literature.
Case presentation
A 62-year-old woman (A.K., #5202) applied to our insti-
tute with complaints of nausea and vomiting. She
described four episodes of similar type, each lasting 2 to 3
days, in the last 4 months. Her medical background and
family history were unremarkable and physical examina-
tion was normal. The standard laboratory results (whole
blood count, glucose, blood urea nitrogen, creatinine,
electrolytes, prothrombin time, and partial thromboplas-
tin time) were also within normal limits. Upper gastroin-
testinal endoscopy revealed a 30 mm prepyloric sessile
polyp covered with normal mucosa and which partially
obstructed the entrance of the pyloric channel Figure 1A.
The patient's gastric outlet obstruction was ascribed to this
pathology and a polypectomy was carried out in the same
session. The polyp was slightly elevated by submucosal
injection of diluted adrenaline solution (0.0125 mg/mL
in saline) targeted at 4 points around the base Figure 1B.
The polyp was removed with a snare and diathermy was
used at a level of 40 watts Figure 1C. Two biopsies were
taken from both the antrum and the corpus for rapid ure-
ase test. Four samples from each sites of the greater curva-
ture of the antrum and the corpus were also taken to assess
any atrophy, intestinal metaplasia or gastritis. Rapid ure-
ase test for H. pylori yielded a negative result. Histopatho-
logic examination of the polypectomy specimen showed
a hyperplastic polyp without any malignant features Fig-
ure 2. Biopsies of the antrum and the corpus revealed gas-
tritis with no evidence of atrophic changes or intestinal
metaplasia. H. pylori was not observed by either Hematox-
ylin and Eosin or modified Giemsa stains. Follow-up
endoscopy after a 12-week course of proton pomp inhib-
itor (PPI) therapy showed a complete healing of the
polypectomy site with no remnant tissue related to the
polyp Figure 3. The patient has been symptom-free during
8 months of follow-up.
Conclusions
Most hyperplastic polyps are usually small (< 2 cm); how-
ever, larger polyps may seldom be encountered on endo-
scopic examinations. Larger the size of the polyps, higher
is the risk of the complications such as obstruction or
bleeding. Rarely, hyperplastic polyps may cause dramatic
clinical pictures. De La Cruz et al. [14] reported a patient
with a hyperplastic polyp that caused pancreatitis by pro-
lapsing into the duodenum and compressing the Vater
ampulla. Alper et al. [6] showed that a large pedunculated
antral hyperplastic polyp may cause gastric outlet obstruc-
tion and iron deficiency anemia by prolapsing into the
duodenum through the pyloric channel. More frequent
use of gastroscopic examinations resulted in an increase of
incidental diagnosis of hyperplastic polyps. Although it
has been widely accepted that every symptomatic polyp
should be removed either endoscopically or surgically,
there is no particular guideline regarding the evaluation
and treatment of asymptomatic hyperplastic polyps.
The exact pathogenesis of hyperplastic polyps is still
unclear. The current theory is that an exaggerated regener-
ative response to mucosal damage occurs [8]. They may be
found in association with various forms of chronic gastri-
tis, notably with autoimmune or H. pylori gastritis [9].
Abraham et al. [9] investigated 160 patients with hyper-
plastic polyps and found that 85% of the cases had an
associated inflammatory mucosal pathology, mostly H.
pylori gastritis. Not only inflammatory changes, but also
malignant foci in other parts of the gastric mucosa may be
detected in patients with hyperplastic polyps. Accord-
ingly, taking biopsies from the remote gastric mucosa in
order to evaluate any inflammatory changes or malignant
transformation has been advocated [15].
There is still a debate on whether H. pylori promotes the
development of hyperplastic polyps. In a series of 21
patients with gastric hyperplastic polyp, H. pylori was pos-
itive in 76% of the patients [12]. However, in another
larger series, 85% (136/160) of the patients had inflam-
matory mucosal pathology, most commonly active
chronic H. pylori gastritis (25%) [9]. On the other hand,
Varis et al. [16] investigated the presence of H. pylori in
patients with different types of gastric polyps and reported
the prevalence of H. pylori infection significantly lower in
patients with hyperplastic polyps (45%) and foveolar
hyperplasia (48%) than in the group with inflammatory
polyps (81%). As an interesting observation, Ohkusa et al.
[13] showed that hyperplastic polyps disappeared afterPage 2 of 4
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associated gastritis. Similarly, Ljubicic et al. [12] reported
a 40% complete regression rate of hyperplastic polyps in
patients who had associated H. pylori gastritis after an
average follow-up of 14 months. In both trials, endo-
scopic polypectomy has been recommended as the sec-
ond-line approach in the management of hyperplastic
A prepyloric polyp causing obstruction at the pyloric channelFigure 1
A) A prepyloric polyp causing obstruction at the pyloric 
channel. B)Injection of diluted adrenaline solution to the 
base of the polyp. C) Removal of the polyp with a snare.
Hyperplastic surface epithelium and cystically dilated glands with inf mmatory infiltration and smoo h musc e cells i  lamina propria, X40, H+EFigure 2
Hyperplastic surface epithelium and cystically dilated glands 
with inflammatory infiltration and smooth muscle cells in 
lamina propria, X40, H+E.
A complete healing at the polypectomy site was observed on the follow-up endoscopy after a 12-week cour e of PPI rapyFigure 3
A complete healing at the polypectomy site was observed on 
the follow-up endoscopy after a 12-week course of PPI 
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polyps associated with H. pylori gastritis, when eradication
therapy fails to achieve complete polyp regression
[12,13]. However, this approach has not been unani-
mously accepted. The policy in our institute is to remove
single polyps of any diameter regardless whether the
patient has or not associated H. pylori gastritis. When there
are multiple polyps, the strategy is determined by the
results of H. pylori urease test: if negative, all the polyps are
removed; but if positive, polyps larger than 15 mm in
diameter are removed whereas sampling polypectomy
and eradication therapy are offered to the smaller ones.
Then, these patients are submitted to endoscopic
surveillance.
Contrary to the previous belief, recent studies have
revealed that hyperplastic polyps may include dysplastic
foci and even undergo malignant degeneration [10,11].
Hizawa et al. [11] reported the incidence of malignancy in
the hyperplastic polyps as 2%.
In summary, symptomatic gastric polyps presenting as the
case above should be removed preferentially when they
are detected at the initial diagnostic endoscopy. Polypec-
tomy not only provides tissue to determine the exact his-
topathologic type of the polyp, but also achieves radical
treatment. The same strategy can be used for asympto-
matic polyps, where biopsy samples may yield inconclu-
sive results by sampling error. Evidence now is in favour
of polypectomy even though the histopathologic exami-
nation shows that these are hyperplastic polyps. Addition-
ally, in patients with gastric polyps, other parts of the
gastric mucosa should also be histologically evaluated by
multiple biopsies for detection of any accompanying
inflammatory changes or malignancy. After polypectomy,
endoscopic follow-up can be recommended, because of
the possibility of recurrence at the polypectomy site and
of development of malignancy in the remote gastric
mucosa.
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